Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/91509
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWiese, M.en
dc.contributor.authorHopkins, A.en
dc.contributor.authorSpargo, L.en
dc.contributor.authorMcWilliams, L.en
dc.contributor.authorO'Doherty, C.en
dc.contributor.authorCleland, L.en
dc.contributor.authorProudman, S.en
dc.date.issued2014en
dc.identifier.citationAustralian Rheumatology Association in conjunction with Rheumatology Health Professionals Association 55th Annual Scientific Meeting, as published in Internal Medicine Journal, 2014 / vol.44, iss.Suppl. S2, pp.3en
dc.identifier.issn1444-0903en
dc.identifier.issn1445-5994en
dc.identifier.urihttp://hdl.handle.net/2440/91509-
dc.descriptionOral abstract ARA9en
dc.description.statementofresponsibilityWiese M, Hopkins A, Spargo L, McWilliams L, O, Doherty C, Cleland L, Proudman Sen
dc.language.isoenen
dc.publisherWiley-Blackwellen
dc.rights© 2014 The Authorsen
dc.titleA pilot study to assess the impact of patient, genetic and disease factors on response to the disease modifying anti-rheumatic drug leflunomideen
dc.typeConference itemen
dc.identifier.rmid0030014841en
dc.contributor.conferenceAustralian Rheumatology Association 55th Annual Scientific Meeting (17 May 2014 - 20 May 2014 : Hobart, Tasmania)en
dc.identifier.doi10.1111/imj.12424en
dc.identifier.pubid151768-
pubs.library.collectionMedicine publicationsen
pubs.library.teamDS02en
pubs.verification-statusVerifieden
pubs.publication-statusPublisheden
dc.identifier.orcidProudman, S. [0000-0002-3046-9884]en
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.